FDA Approved: QELBREE — Supplemental Application (Supernus Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for QELBREE (viloxazine hydrochloride) from Supernus Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• QELBREE (viloxazine hydrochloride)

Snippet

SUPPL AP for QELBREE (VILOXAZINE HYDROCHLORIDE)